RadNet, Inc. Shares Issued, Value, Share-based Payment Arrangement, Forfeited
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2025-03-31 was $20.00K, a 122.22% increase year-over-year.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2024-12-31 was $115.00K.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2024-09-30 was $4.00K.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for the quarter ending 2024-06-30 was $25.00K.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for fiscal 2024 was $153.00K.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for fiscal 2022 was $75.00K, a 7.41% decline from fiscal 2021.
- RadNet, Inc. shares issued, value, share-based payment arrangement, forfeited for fiscal 2021 was $81.00K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, Forfeited 3 month | Shares Issued, Value, Share-based Payment Arrangement, Forfeited 12 month |
|---|---|---|
| 2025-03-31 | $20.00K 10-Q · filed 2025-05-12 | $164.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $153.00K 10-K · filed 2025-03-03 |
| 2024-09-30 | $4.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $25.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $9.00K 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2022-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $75.00K 10-K · filed 2025-03-03 |
| 2021-12-31 | $81.00K 10-K · filed 2024-02-29 | |
| 2021-09-30 | $42.00K 10-Q · filed 2022-11-09 | |
| 2019-12-31 | $5.00K 10-K · filed 2022-03-01 | |
| 2018-12-31 | $7.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |